Hospital Pharmacy - May 2017 - 330

715349
research-article2017

HPXXXX10.1177/0018578717715349Hospital PharmacyMancano

ISMP Adverse Drug Reactions
Hospital Pharmacy
2017, Vol. 52(5) 330-333
© The Author(s) 2017
Reprints and permissions:
sagepub.com/journalsPermissions.nav
https://doi.org/10.1177/0018578717715349
DOI: 10.1177/0018578717715349
journals.sagepub.com/home/hpx

ISMP Adverse Drug Reactions:
Levofloxacin-Induced Neuroexcitation and Hallucinations
Statin-Induced Muscle Rupture
Mefloquine-Induced Rhabdomyolysis
Methimazole-Induced Cholestatic Hepatitis
Decitabine-Induced Hand and Foot Syndrome
Michael A. Mancano1,2

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of
prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA) MedWatch program (800FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with
our readers. Write to Dr. Mancano at ISMP, 200 Lakeside Drive, Suite 200, Horsham, PA 19044 (phone: 215-707-4936;
e-mail: mmancano@temple.edu). Your report will be published anonymously unless otherwise requested. This feature is
provided by the Institute for Safe Medication Practices (ISMP) in cooperation with the FDA's MedWatch program and
Temple University School of Pharmacy. ISMP is an FDA MedWatch partner.

Levofloxacin-Induced Neuroexcitation
and Hallucinations
A 2-year-old girl was admitted to the hospital after central
line placement prior to receiving a stem cell transplant. She
had a history of stage IV neuroblastoma and tolerated her
induction therapy well. She had a history of Klebsiella sepsis
and 2 episodes of neutropenic fever. She did not have any
emotional, cognitive, or behavioral disturbances; no previous psychiatric history; and no previous use of psychotropic
medication.
On day 1 of her admission, busulfan was initiated and
continued until day 5. On day 5, the patient received levofloxacin (Levaquin) prophylaxis according to an oncology
protocol for bone marrow transplantation. The patient
received levofloxacin daily until the time of engraftment.
Other medications the patient had received during this time
were acyclovir prophylaxis, fluconazole prophylaxis, ondansetron as needed, lorazepam as needed, aprepitant as needed,
cyproheptadine, cholecalciferol, omeprazole, ursodiol, oxycodone as needed, and morphine as needed.
The patient received levofloxacin at 12:12 a.m. and 8:20
p.m. on hospital day 5. Overnight, the patient's mother
reported that the patient experienced sleep disturbances with
episodes of agitation, disorientation, swatting at things that
were not there, and pinching herself. On the sixth day, the
patient did not exhibit any behavioral, cognitive, or emotional disturbances during the day. She received levofloxacin
at 9:11 a.m. and 10:38 p.m. on day 6. In the evening, she

exhibited agitation, disorientation, psychomotor agitation,
aggression, and a change in mood. She was swatting at
nurses, pulling on her garments, and crying excessively. She
developed tactile hallucinations in which she described bugs
crawling on her lower extremities. A psychiatry consult was
completed, and the patient was given a provisional diagnosis
of delirium. Psychiatry recommended that the patient's exposure to benzodiazepines be limited. The patient's mother
noted a history of similar symptoms after the patient had
received levofloxacin. Based on this information, the oncology team adjusted the dosing of levofloxacin to an earlier
time in the day.
The patient received an autologous bone marrow transplant on hospital day 7. Her second dosage of levofloxacin
was adjusted to be administered at 4:00 p.m., and melatonin
was given at 9:45 p.m. She did not experience any change in
her behavior overnight. On day 8, her second levofloxacin
dosage was administered at 6:47 p.m. and her melatonin was
given at 8:03 p.m. The patient awoke overnight with a brief
episode of visual and tactile hallucinations. This episode was
short and she exhibited less agitation and aggression overall.
1

Temple University School of Pharmacy, Philadelphia, PA, USA
Institute for Safe Medication Practices, Horsham, PA, USA

2

Corresponding Author:
Michael A. Mancano, Chair and Clinical Professor, Department of
Pharmacy Practice, Temple University School of Pharmacy, Philadelphia,
PA 19140, USA.
Email: michael.mancano@temple.edu


https://us.sagepub.com/en-us/journals-permissions http://journals.sagepub.com/doi/10.1177/0018578717715349 http://journals.sagepub.com/home/hpx

Table of Contents for the Digital Edition of Hospital Pharmacy - May 2017

Editorial, For Sale: FDA Priority Review Vouchers
Current FDA-Related Drug Information; Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals
Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings
ISMP Adverse Drug Reactions: Levofloxacin-Induced Neuroexcitation and Hallucinations Statin-Induced Muscle Rupture Mefloquine-Induced Rhabdomyolysis Methimazole-Induced
Critical Care Pharmacist Market Perceptions: Comparison of Critical Care Program Directors and Directors of Pharmacy
Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer
Clinical Pharmacy Discharge Counseling Service and the Impact on Readmission Rates in High-Risk Patients
Mannitol Prescribing Practices With Cisplatin Before and After an Educational Newsletter Intervention
Pharmacists’ Knowledge of the Cost of Laboratory Testing
Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers
Postoperative Pain Management With Liposomal Bupivacaine in Patients Undergoing Orthopedic Knee and Hip Arthroplasty at a Community Hospital
Formulary Drug Reviews
Hospital Pharmacy - May 2017 - 317
Hospital Pharmacy - May 2017 - 318
Hospital Pharmacy - May 2017 - 319
Hospital Pharmacy - May 2017 - 320
Hospital Pharmacy - May 2017 - 321
Hospital Pharmacy - May 2017 - 322
Hospital Pharmacy - May 2017 - 323
Hospital Pharmacy - May 2017 - Editorial, For Sale: FDA Priority Review Vouchers
Hospital Pharmacy - May 2017 - 325
Hospital Pharmacy - May 2017 - Current FDA-Related Drug Information; Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals
Hospital Pharmacy - May 2017 - Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings
Hospital Pharmacy - May 2017 - 328
Hospital Pharmacy - May 2017 - 329
Hospital Pharmacy - May 2017 - ISMP Adverse Drug Reactions: Levofloxacin-Induced Neuroexcitation and Hallucinations Statin-Induced Muscle Rupture Mefloquine-Induced Rhabdomyolysis Methimazole-Induced
Hospital Pharmacy - May 2017 - 331
Hospital Pharmacy - May 2017 - 332
Hospital Pharmacy - May 2017 - 333
Hospital Pharmacy - May 2017 - Critical Care Pharmacist Market Perceptions: Comparison of Critical Care Program Directors and Directors of Pharmacy
Hospital Pharmacy - May 2017 - 335
Hospital Pharmacy - May 2017 - 336
Hospital Pharmacy - May 2017 - 337
Hospital Pharmacy - May 2017 - 338
Hospital Pharmacy - May 2017 - 339
Hospital Pharmacy - May 2017 - 340
Hospital Pharmacy - May 2017 - Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer
Hospital Pharmacy - May 2017 - 342
Hospital Pharmacy - May 2017 - 343
Hospital Pharmacy - May 2017 - 344
Hospital Pharmacy - May 2017 - 345
Hospital Pharmacy - May 2017 - 346
Hospital Pharmacy - May 2017 - 347
Hospital Pharmacy - May 2017 - Clinical Pharmacy Discharge Counseling Service and the Impact on Readmission Rates in High-Risk Patients
Hospital Pharmacy - May 2017 - 349
Hospital Pharmacy - May 2017 - 350
Hospital Pharmacy - May 2017 - 351
Hospital Pharmacy - May 2017 - 352
Hospital Pharmacy - May 2017 - Mannitol Prescribing Practices With Cisplatin Before and After an Educational Newsletter Intervention
Hospital Pharmacy - May 2017 - 354
Hospital Pharmacy - May 2017 - 355
Hospital Pharmacy - May 2017 - 356
Hospital Pharmacy - May 2017 - Pharmacists’ Knowledge of the Cost of Laboratory Testing
Hospital Pharmacy - May 2017 - 358
Hospital Pharmacy - May 2017 - 359
Hospital Pharmacy - May 2017 - 360
Hospital Pharmacy - May 2017 - Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers
Hospital Pharmacy - May 2017 - 362
Hospital Pharmacy - May 2017 - 363
Hospital Pharmacy - May 2017 - 364
Hospital Pharmacy - May 2017 - 365
Hospital Pharmacy - May 2017 - 366
Hospital Pharmacy - May 2017 - Postoperative Pain Management With Liposomal Bupivacaine in Patients Undergoing Orthopedic Knee and Hip Arthroplasty at a Community Hospital
Hospital Pharmacy - May 2017 - 368
Hospital Pharmacy - May 2017 - 369
Hospital Pharmacy - May 2017 - 370
Hospital Pharmacy - May 2017 - 371
Hospital Pharmacy - May 2017 - 372
Hospital Pharmacy - May 2017 - 373
Hospital Pharmacy - May 2017 - Formulary Drug Reviews
Hospital Pharmacy - May 2017 - 375
Hospital Pharmacy - May 2017 - 376
Hospital Pharmacy - May 2017 - 377
Hospital Pharmacy - May 2017 - 378
Hospital Pharmacy - May 2017 - 379
Hospital Pharmacy - May 2017 - 380
Hospital Pharmacy - May 2017 - 381
Hospital Pharmacy - May 2017 - 382
Hospital Pharmacy - May 2017 - 383
Hospital Pharmacy - May 2017 - 384
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2019
http://www.nxtbook.com/nxtbooks/sage/fai_201909
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_july2019
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2019
http://www.nxtbook.com/nxtbooks/sage/canadianpharmacistsjournal_05062019
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2019
http://www.nxtbook.com/nxtbooks/sage/sri_supplement_201903
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2019
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2018
http://www.nxtbook.com/nxtbooks/sage/tec_20180810
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2018
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2018
http://www.nxtbook.com/nxtbooks/sage/fai_201807
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2018
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2018
http://www.nxtbook.com/nxtbooks/sage/sri_supplement_201803
http://www.nxtbook.com/nxtbooks/sage/slas_discovery_201712
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2018
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_november2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_september2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2017
http://www.nxtbook.com/nxtbooks/sage/fai_supplement_201709
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_may2017
http://www.nxtbook.com/nxtbooks/sage/fai_201706
http://www.nxtbook.com/nxtbooks/sage/fai_201607
http://www.nxtbookMEDIA.com